Assessment of safety of performing percutaneous coronary intervention after a recent episode of gastrointestinal bleeding

Acute Card Care. 2016 Mar;18(1):1-6. doi: 10.3109/17482941.2016.1174269. Epub 2016 Oct 27.

Abstract

Background: Little literature exists on the risk of performing coronary intervention (PCI) on patients who have had recent gastrointestinal bleeding (GIB), although bleeding after PCI has been identified as a risk factor for long-term mortality.

Methods: Patients within the Cleveland Clinic PCI database who had acute GIB within 30 days preceding PCI during the same hospitalization (n = 79) were retrospectively compared to those who had PCI without recent GIB (n = 10 979) for mortality and need for revascularization. Baseline characteristics, laboratory values, procedures, morbidities, and mortality were compared using chi-square test for categorical variables and using Wilcoxon rank sum test for continuous variables. Mortality data was obtained using Social Security Death Index and demonstrated using Kaplan-Meier method.

Results: The GIB group had more prevalent history of peptic ulcer disease, GIB, gastrointestinal or liver disease (P < 0.0001), transient ischemic accident (P = 0.017), peripheral vascular disease (P = 0.0002), significant carotid artery occlusion (P = 0.023), and myocardial infarction (P < 0.0001). 47% of patients had upper GIB with 20% needing endoscopic intervention. This group had more anemia (P < 0.0001), heart failure (P = 0.0001), cardiogenic shock (10% versus 1.4%, P < 0.001), cardiac arrest (7.6% versus 1%, P < 0.001). GIB group had worse in-hospital mortality (P < 0.0001), long-term mortality (P < 0.001), and a 7.6% re-bleeding incidence.

Conclusions: Overall, the patients who had GIB preceding PCI had higher in-hospital mortality and long-term mortality compared with those without GIB before PCI.

Keywords: Angina; Gastrointestinal bleeding; angiography; mortality; re-bleeding; revascularization.

MeSH terms

  • Aged
  • Coronary Disease* / complications
  • Coronary Disease* / drug therapy
  • Coronary Disease* / mortality
  • Coronary Disease* / surgery
  • Female
  • Gastrointestinal Diseases / complications*
  • Gastrointestinal Diseases / epidemiology
  • Gastrointestinal Hemorrhage* / epidemiology
  • Gastrointestinal Hemorrhage* / etiology
  • Gastrointestinal Hemorrhage* / therapy
  • Hospital Mortality
  • Humans
  • Incidence
  • Long Term Adverse Effects / etiology
  • Long Term Adverse Effects / mortality
  • Male
  • Middle Aged
  • Outcome and Process Assessment, Health Care
  • Percutaneous Coronary Intervention* / adverse effects
  • Percutaneous Coronary Intervention* / methods
  • Platelet Aggregation Inhibitors / administration & dosage
  • Platelet Aggregation Inhibitors / adverse effects
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • United States / epidemiology

Substances

  • Platelet Aggregation Inhibitors